Screener
PBE vs QBIG
Invesco Biotechnology & Genome ETF vs Invesco Top QQQ ETF
Key differences
- QBIG costs 0.29% less per year.
- PBE is significantly larger than QBIG — larger funds tend to be more liquid and less likely to close.
- PBE follows a index tracking strategy; QBIG uses active selection.
- PBE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PBE | QBIG | |
|---|---|---|
| Annual cost (TER) | 0.58% | 0.29% |
| Fund size (AUM) | $247M | $36M |
| Since | 2005 | 2024 |
| Dividend yield | 1.09% | 0.00% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | active selection |
| CAGR 1Y | +34.1% | +41.4% |
| CAGR 3Y | +10.3% | N/A |
| CAGR 5Y | +3.3% | N/A |
| Sharpe 3Y | 0.41 | N/A |
| Volatility 1Y | 18.63% | 19.60% |
| Max drawdown | -37.84% | -30.33% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PBE and QBIG
Explore further